NIH Awards PathMaker $371K to Advance Neuromodulation Therapy

NIH Awards PathMaker $371K to Advance Neuromodulation Therapy

307182

NIH Awards PathMaker $371K to Advance Neuromodulation Therapy

PathMaker Neurosystems was awarded $371,000 from the National Institutes of Health (NIH) to advance its neuromodulation technology as a potential new, non-invasive treatment for amyotrophic lateral sclerosis (ALS). The Small Business Technology Transfer grant, from the NIH’s National Institute of Neurological Disorders and Stroke, will enable PathMaker to complete its investigations, in mouse models of ALS, of its proprietary product that suppresses motor neuron hyperexcitability. Motor neuron hyperexcitability is a common feature of ALS in…

You must be logged in to read/download the full post.